Is there a role for Helicobacter pylori infection in urological diseases?

Mohammed S Al-Marhoon1

  • 1Department of Urology, Mansoura University, Urology and Nephrology Center, Mansoura, Egypt. almarhoon@hotmail.com

Urology Journal
|October 1, 2008
PubMed

Insights

Helicobacter pylori (H pylori) infection is linked to urological conditions like bladder lymphoma and potentially prostate cancer. Further research into H pylori

Area of Science:

  • Urology
  • Gastroenterology
  • Oncology

Background:

  • Helicobacter pylori (H pylori) infection is increasingly recognized for causing both gastrointestinal and extra-intestinal disorders.
  • The bacterium's potential impact on urological health is an emerging area of research.

Purpose of the Study:

  • To investigate the association between Helicobacter pylori infection and various urological diseases.
  • To provide urologists with updated information on this subject.

Main Methods:

  • A comprehensive literature search was conducted using Medline and PubMed databases.
  • The search covered publications from 1950 to December 2007.
  • Keywords included 'Helicobacter pylori' combined with terms related to urology and specific urological conditions.

Main Results:

  • Evidence suggests a link between H pylori infection and urological diseases.
  • H pylori infection is implicated in the development of chronic cystitis, potentially leading to bladder lymphoma.
  • Epidemiological studies indicate a significant association between chronic prostatitis and prostate cancer.

Conclusions:

  • A hypothetical model is proposed to link H pylori infection to prostate and bladder diseases.
  • Further collaborative research between urologists and scientists is needed to explore this underinvestigated field.
  • Eradication of H pylori may offer a preventive strategy for bladder and prostate cancers, similar to its role in treating peptic ulcer disease and gastric cancer.
Abstract

Related Concept Videos

Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...